Page 6 of articles about mycoplasma
New Fostera PCV is the only single-dose vaccine that helps prevent PCV2 viremia
Effect of cross-fostering on transfer of maternal immunity to Mycoplasma hyopneumoniae to piglets
Russia - Temporary restrictions on import of breeding animals from a number of Danish farms
Improvement of environmental quality as a method of PRDC prevention
Day one Mycoplasma hyopneumoniae vaccination now possible with RespiSure-ONE®
Intervet/Schering-Plough animal health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swine
Long-distance airborne transport of infectious PRRSV and Mycoplasma hyopneumoniae from a swine population infected with multiple viral variants
First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union
Intervet/Schering-Plough Animal Health receives positive opinion in europe for simultaneous use of Porcilis® PRRS and Porcilis® M hyo vaccines in piglets
A study on the severity and relevance of porcine circovirus type 2 infections in Dutch fattening pigs with respiratory diseases
Diagnosis of Porcine Respiratory and Reproductive Syndrome
Diagnostic tests for enzootic pneumonia (Mycoplasma hyopneumoniae)
Genetic resistance to disease – An Introduction
Biosecurity measures to prevent pig farms being infected by wild animals
Risk and/or triggering factors of porcine circovirus
Between 1995 and 1997, at the beginning of an epizootic called “maladie de l’amagrissement du porcelet” (MAP), it was observed that the farms that were most affected and that had the most losses, generally presented obvious deviations from what we would consider to be a suitable management of the animals and facilities. This is why Dr. François Madec made a list of management practices with the aim of improving the anomalous situation observed.